Die Universität Basel wurde 1460 nach dem Vorbild der Universitäten Bologna und Paris im Kontext des europäischen Humanismus gegründet. Sie ist die älteste Universität in der Schweiz und gehört zu den ältesten Universitäten Europas. In ihrer langen Geschichte hat sie sich immer wieder neuen Bedingungen angepasst, aber auch selber Entwicklungen angestossen, Veränderungen in Gesellschaft, Wirtschaft und Kultur reflektiert und gestaltet. Seit der Gründungszeit zeichnete sich die Universität als Ort der kulturellen Reflexion aus. Wissenschaftlich war sie seit ihren Anfängen durch die Breite ihres Fächerangebots gekennzeichnet. Diese Tradition hat sie bis heute bewahrt und sich gleichzeitig zu einer der im internationalen Vergleich erfolgreichsten Universitäten entwickelt.

PhD position on novel mRNA nanotherapeutics against antibiotic-resistant pulmonary infections (P2405)

position for 4 years, earliest starting date: 1 January 2025

The Swiss Nanoscience Institute (SNI) at the University of Basel invites highly motivated scientists to apply for the SNI PhD program in Nanoscience.

Your position

Antimicrobial resistance (AMR) is a global health concern. In recent decades, pan-resistant bacteria have emerged, rendering commonly available antibiotics ineffective. Consequently, many pivotal advancements in modern medicine are now under threat. As the development of new antimicrobials stagnates, there is an urgent need for alternative strategies to identify clinically effective treatments. In this project, we aim to develop a novel strategy for the treatment of antibiotic-resistant pulmonary infections via taking advantage of nanoparticle and mRNA technologies. MRNA technology has gained significant attention in various therapeutic areas, particularly in the development of vaccines for COVID-19. However, the potential of mRNA therapies against antimicrobial resistance has not yet been explored. With this project, we aim to bring the mRNA therapeutics beyond the current state-of-the-art.

Your profile

We expect candidates to have a relevant background in biology, chemistry, nanosciences, or a similar field (Master's degree required). Prior experience in at least one of the followings is a must: microbiology (growth curves, inhibition assays,etc.), molecular biology (mRNA transfection, mammalian cell culture, etc.), nanoformulation development (lipid nanoparticles, polymer nanoparticles, liposomes, etc.). Over the course of the project, the candidate will acquire a wide range of skills in nanoformulation development, mRNA delivery, transfection, microbial and mammalian cell cultures

We offer you

We are looking for a PhD student for a joint research activity between Biointerfaces Group at the University of Applied Sciences & Arts Northwestern Switzerland (https://www.nanobiointerfaces.ch), Infection Biology Group at the University of Basel (https://biomedizin.unibas.ch/en/research/research-groups/khanna-gremmelmaier-lab/), and the Nanopharmaceutical and Regulatory Science Group at the University of Basel
(

https://pharma.unibas.ch/de/research/research-groups/nanopharmaceutical-regulatory-science/

www.unibas.ch